Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension.
about
Unique aspects of the developing lung circulation: structural development and regulation of vasomotor toneOxidative Stress and Therapeutic Development in Lung DiseasesHeat shock regulates the respiration of cardiac H9c2 cells through upregulation of nitric oxide synthasePrenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheepNogo-B receptor modulates angiogenesis response of pulmonary artery endothelial cells through eNOS couplingProtein complex formation with heat shock protein 90 in chronic hypoxia-induced pulmonary hypertension in newborn piglets.Voltage-dependent anion channel-2 interaction with nitric oxide synthase enhances pulmonary artery endothelial cell nitric oxide productionHyperthermia-induced Hsp90·eNOS preserves mitochondrial respiration in hyperglycemic endothelial cells by down-regulating Glut-1 and up-regulating G6PD activity.Impaired cerebral angiogenesis in the fetal lamb model of persistent pulmonary hypertension.Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb modelAltered pulmonary artery endothelial-smooth muscle cell interactions in experimental congenital diaphragmatic hernia.Sepiapterin improves angiogenesis of pulmonary artery endothelial cells with in utero pulmonary hypertension by recoupling endothelial nitric oxide synthase.Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.Cross talk between NADPH oxidase and autophagy in pulmonary artery endothelial cells with intrauterine persistent pulmonary hypertensionThe role of peroxisome proliferator-activated receptors in pulmonary vascular disease.The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow.Interaction of endothelial nitric oxide synthase with mitochondria regulates oxidative stress and function in fetal pulmonary artery endothelial cells.Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signalingDecreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension.Decreases in manganese superoxide dismutase expression and activity contribute to oxidative stress in persistent pulmonary hypertension of the newborn.AMP kinase activation improves angiogenesis in pulmonary artery endothelial cells with in utero pulmonary hypertension.The NF-κB inhibitory proteins IκBα and IκBβ mediate disparate responses to inflammation in fetal pulmonary endothelial cells.Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitroEndothelial colony-forming cell conditioned media promote angiogenesis in vitro and prevent pulmonary hypertension in experimental bronchopulmonary dysplasiaNogo-B Receptor Modulates Pulmonary Artery Smooth Muscle Cell Function in Developing Lungs.Antenatal betamethasone improves postnatal transition in late preterm lambs with persistent pulmonary hypertension of the newborn.Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitrationIncreased superoxide production contributes to the impaired angiogenesis of fetal pulmonary arteries with in utero pulmonary hypertension.Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn.Nitric oxide and beyond: new insights and therapies for pulmonary hypertension.Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension.Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia.Increased nitric oxide synthase activity and Hsp90 association in skeletal muscle following chronic exercise.Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.PPARgamma as a potential therapeutic target in pulmonary hypertension.Neonatal pulmonary hypertension.The physiological role of endoglin in the cardiovascular system.Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.Novel assessment of haemodynamic kinetics with acute exercise in a rat model of pulmonary arterial hypertension.
P2860
Q28076917-9A1F6C3E-CE3C-4567-9361-D456C094D217Q28390572-39A269DF-2434-4547-8466-F9F0348E9175Q28565622-31BE4283-8D2A-49B1-82DF-BE3AE2550297Q33806234-21E1175D-6D66-4AC9-A793-DE341CE83165Q34103713-5F998FB6-38E7-44D8-876F-9151993348A4Q34212244-AAA6740A-B04D-4435-93D0-1A6C001E43F0Q34290941-0FE55EE9-3C07-4AE6-BA3D-0B1E47F619D4Q34352151-7D6AC96C-BA92-4C47-A67A-0F168D0BB80FQ34714127-711AD051-BA44-4D7F-B63B-6B0E71CE3EC6Q34897476-11E6471C-90C8-4625-94ED-780A29795DB2Q35137429-4A8E406B-6E77-4A65-807E-CE9E3A902FD6Q35186599-54A7B2A4-ADC9-4611-AD97-C13310E90625Q35217368-CF6A4149-40B2-42C9-B834-9ADD2C4EB23BQ35792731-601E5574-F158-4C26-BEF2-FD62BD659BB0Q35900814-D6133B08-E001-4E14-8EB5-EF6572CC9915Q35925357-96A8F39B-98D9-42F6-9B96-D2D95CF2E9BEQ36202755-5D521202-A106-4949-8987-2C45ABE43F27Q36237207-ADF30A91-6F84-4B65-B7DB-DBA5ABC2CE5CQ36330558-7256F55E-9A04-4DB6-9CEC-05820EC02843Q36422633-EADD2945-5048-40D4-997F-A1DDACB6F78EQ36454374-4D801181-B782-4D90-9A33-C14EDC600880Q36527961-47D77CA9-4440-4269-9B7C-03641D89883CQ36674163-ABCBAA13-610E-468E-956F-E7B808D2BF27Q36956200-DB51A968-9E9E-447D-9D10-FB773291B4CBQ37054468-8B5F2462-C849-406B-A011-671832CDD45EQ37088308-0242753C-1F14-4EEA-8C10-CB5F41762580Q37112135-92514AC5-FA88-4FA5-BF28-BA648E097035Q37241319-00406F30-18E5-462B-9525-50695F31D4EFQ37264733-D7F9BB07-301D-43AD-B7E2-1028351EB575Q37340559-A88D7E05-435B-42E8-802F-C26C2D35920CQ37341675-9B486075-7C19-48B2-AF9F-CE551BFC69B2Q37436986-0B490409-01F7-499B-85B4-2BB2FC083A07Q37440542-355E76E3-3C5D-4276-AF43-898F836507C0Q37448355-849BEDF9-8023-4889-B322-21E0816CDB06Q37510031-5A8024C1-058C-428A-B872-D99875F8327FQ37689190-C450CF28-5351-4FE9-82F3-5FDA33591C92Q37705885-5241B38E-9332-4C87-B2D6-DD75A2C1C307Q37775427-E76A8F7D-7846-4EFA-9C90-7E7934641615Q37893072-0CFB0F72-D8E5-4D05-B770-20E87D59C8CEQ39018693-FD017242-6532-4825-8929-21FACDEA1909
P2860
Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Decreased association of HSP90 ...... istent pulmonary hypertension.
@en
Decreased association of HSP90 ...... istent pulmonary hypertension.
@nl
type
label
Decreased association of HSP90 ...... istent pulmonary hypertension.
@en
Decreased association of HSP90 ...... istent pulmonary hypertension.
@nl
prefLabel
Decreased association of HSP90 ...... istent pulmonary hypertension.
@en
Decreased association of HSP90 ...... istent pulmonary hypertension.
@nl
P2093
P2860
P1476
Decreased association of HSP90 ...... istent pulmonary hypertension.
@en
P2093
Girija G Konduri
Jingsong Ou
Kirkwood A Pritchard
P2860
P304
P356
10.1152/AJPHEART.00837.2002
P577
2003-03-27T00:00:00Z